Mutational landscape of chronic myelomonocytic leukemia in Chinese patients

被引:0
作者
Yanbo Nie
Liang Shao
Hong Zhang
Colin K. He
Hongyu Li
Junyan Zou
Long Chen
Huaiyue Ji
Hao Tan
Yani Lin
Kun Ru
机构
[1] Sino-US Diagnostics Lab,Department of Hematology
[2] Tianjin Enterprise Key Laboratory of AI-aided Hematopathology Diagnosis,undefined
[3] Zhongnan Hospital of Wuhan University,undefined
[4] Stego Tech LLC,undefined
来源
Experimental Hematology & Oncology | / 11卷
关键词
CMML; Gene mutation; Clonal evolution; Secondary AML (sAML); Overall survival (OS);
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 257 条
[1]  
Lee SC(2016)Integrating clinical features and genetic lesions in the risk assessment of patients with chronic myelomonocytic leukemia Blood 128 1408-17
[2]  
Dvinge H(2018)Recent updates on chronic myelomonocytic leukemia Curr Hematol Malig Rep 13 446-54
[3]  
Kim E(2019)Update on the pathologic diagnosis of chronic myelomonocytic leukemia Mod Pathol 32 732-40
[4]  
Cho H(2021)A global, regional, and national survey on burden and quality of care index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017 Exp Hematol Oncol 10 11-36
[5]  
Micol JB(2020)Leukemia incidence trends at the global, regional, and national level between 1990 and 2017 Exp Hematol Oncol 19 14-115
[6]  
Chung YR(2013)Prognostic score including gene mutations in chronic myelomonocytic leukemia J Clin Oncol 31 2428-405
[7]  
Elena C(2020)Chronic myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management Am J Hematol 95 97-19
[8]  
Gallì A(2016)The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia Blood 127 2391-42
[9]  
Such E(2018)Diagnosis and treatment of chronic myelomonocytic leukemias in adults: recommendations from the European Hematology Association and the European LeukemiaNet Hemasphere 2 e150-45
[10]  
Meggendorfer M(2017)CMML: clinical and molecular aspects Int J Hematol 105 711-7